Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Spark Therapeutics
Spark Therapeutics
(ONCE)
Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Luxturna
Voretigene neparvovec
2017-12-19
Retinitis pigmentosa
,
Leber congenital amaurosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voretigene neparvovec
retinal dystrophies
,
blindness
,
leber congenital amaurosis
Bevifimod
stroke
,
atherosclerosis
,
intracranial arteriosclerosis
,
fallopian tube neoplasms
,
healthy volunteers/patients
,
neoplasms
,
carcinoma
,
squamous cell carcinoma
,
hypersensitivity
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
ovarian epithelial carcinoma
,
renal cell carcinoma
,
melanoma
,
peanut hypersensitivity
,
allergic rhinitis
,
rhinitis
,
basal cell carcinoma
,
squamous cell carcinoma of head and neck
,
merkel cell carcinoma
,
neoplasm metastasis
,
basal cell neoplasms
,
lung neoplasms
,
lung diseases
,
adenocarcinoma
,
adenocarcinoma of lung
,
milk hypersensitivity
,
multiple myeloma
,
plasma cell neoplasms
,
smoldering multiple myeloma
,
paraproteinemias
,
monoclonal gammopathy of undetermined significance
,
prostatic neoplasms
,
colorectal neoplasms
,
head and neck neoplasms
,
ovarian neoplasms
,
retinal diseases
,
diabetic retinopathy
,
hemorrhage
,
ascites
,
protein-losing enteropathies
,
intestinal diseases
,
myositis ossificans
,
vitreous hemorrhage
,
type 2 diabetes mellitus
,
hyperlipidemias
,
diabetes mellitus
,
macular degeneration
,
hemophilia a
,
hemophilia b
Coagulation factor ix human
hemophilia a
,
hiv infections
Demand
diabetes mellitus
,
type 1 diabetes mellitus
,
healthy volunteers/patients
,
erectile dysfunction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use